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An immunologic hypothesis is currently proposed as
a possible pathogenesis of nonsegmental-type viti-
ligo. IgG antibodies against melanocyte surface anti-
gens exist in the serum of patients with vitiligo
vulgaris. IgG anti-melanocyte antibodies were
reported to induce melanocyte damage in vitro by a
complement-mediated mechanism and antibody-
dependent cellular cytotoxicity. Perilesional melano-
cytes express major histocompatibility complex class
II antigens and a higher intercellular adhesion mole-
cule-1 compared with those in normal skin. The
purpose of this study was to determine the role of
IgG anti-melanocyte antibodies in the inappropriate
expression of major histocompatibility complex class
II antigens and intercellular adhesion molecule-1 on
melanocytes. IgG anti-melanocyte antibody samples
were puri®ed from the individual serum of patients
with active vitiligo. After incubation of IgG anti-
melanocyte antibodies with cultured melanocytes,
the results revealed: (i) IgG anti-melanocyte antibody
stimulated HLA-DR expression on melanocytes; (ii)
intercellular adhesion molecule-1 expression on mel-
anocytes was signi®cantly induced by IgG anti-mela-
nocyte antibodies; and (iii) IgG anti-melanocyte
antibodies induced an increase in interleukin-8
release from melanocytes. The major histocompat-
ibility complex class II molecules expressed in mela-
nocytes can present antigens to CD4 helper cells as
antigen-presenting cells and elicit an immune
response. Intercellular adhesion molecule-1 is an
important adhesion molecule involved in leukocyte
and parenchymal cell interaction and thus plays an
essential part in immunologic and in¯ammatory
reactions. It is reasonable to speculate that abnormal
expressions of HLA-DR and intercellular adhesion
molecule-1 on melanocytes by IgG anti-melanocyte
antibodies would present vitiligo antigens and allow
the antigen-speci®c immune effector cell attack that
results in melanocytotoxicity. Key words: adhesion
molecule/autoantibodies/melanocytotoxicity/major histo-
compatibility complex class II. J Invest Dermatol 115:969±
973, 2000
F
unctional melanocytes in patients with vitiligo vulgaris
disappear from involved skin by a mechanism(s) that has
not yet been identi®ed. An immunologic hypothesis is
currently advanced as a possible pathogenesis of nonseg-
mental-type vitiligo. The presence of anti-melanocyte
antibodies may play particularly important parts in the pathogenesis
of vitiligo (Naughton et al, 1983a, b). IgG anti-melanocyte
antibodies (V-IgG) were found to induce melanocyte damage in
vitro by a complement-mediated mechanism and antibody-
dependent cellular cytotoxicity (Norris et al, 1988). al Badri et al
(1993) reported an increase in major histocompatibility complex
(MHC) class II antigens and intercellular adhesion molecule-1
(ICAM-1) expression in perilesional melanocytes in vitiligo;
however, the mechanism for the abnormal expressions in vitiligo
melanocytes has not yet been clari®ed. As these molecules possess
important roles in cell±cell interactions and activation of helper T
lymphocytes (Marlin and Springer, 1987; Dahl, 1996), their
expression on melanocytes may contribute to the abnormal
immune response in vitiligo (al Badri et al, 1993). Identi®cation
of factors that induce MHC class II antigens and ICAM-1
expression in melanocytes may provide a crucial clue to the
immunologic mechanisms of melanocyte destruction in patients
with vitiligo. This study demonstrates that V-IgG elicits HLA-DR
and ICAM-1 expression and an increase in interleukin (IL)-8
release by melanocytes.
MATERIALS AND METHODS
Puri®cation of IgG from active vitiligo patients and normal
controls Twelve patients with vitiligo of nonsegmental-type were
studied as in our previous report (Yu et al, 1997). All patients had
developed newly depigmented lesions in the previous 3 mo, i.e., they were
suffering from active vitiligo (Moellmann et al, 1982). None of the patients
had known autoimmune disorders. An equal number of age- and sex-
matched healthy individuals served as controls. None of the participants
had received medical treatment in the preceding 3 mo. The sera were
collected from patients and normal controls for puri®cation as in a previous
0022-202X/00/$15.00 ´ Copyright # 2000 by The Society for Investigative Dermatology, Inc.
969
Manuscript received November 2, 1998; revised May 5, 2000; accepted
for publication August 2, 2000.
Reprint requests to: Dr. Hsin-Su Yu, Department of Dermatology,
Kaohsiung Medical University, 100 Shih Chung 1st Road, Kaohsiung,
Taiwan. Email: dermyu@cc.kmu.edu.tw
Abbreviations: MFI, mean ¯uorescence intensity; N-IgG, IgG puri®ed
from normal control; V-IgG, IgG puri®ed from vitiligo patients.
study (Yu et al, 1989). The fraction II (IgG) obtained from Sephacryl S-300
gel ®ltration was further absorbed by the protein A-Sepharose 4B
(Pharmacia LKB, Uppsala, Sweden). Sepharose-conjugated IgG was
eluted with sodium acetate buffer at pH 2.5 and immediately neutralized
to pH 7.2 with 1 N NaOH. After adequate dialysis against distilled water,
the IgG was lyophilized. The protein concentration of puri®ed IgG was
determined by Bio-Rad protein assay kit (Bio-Rad, Richmond, CA).
These IgG preparations were found to contain negligible contaminants
when detected by 10% sodium dodecyl sulfate±polyacrylamide gel
electrophoresis (Laemmli, 1970).
Melanocyte culture The foreskins of adults from routine circumcisions
were cleaned of excess subcutaneous tissue, cut into small pieces
(5 3 5 mm), and incubated with 0.25% trypsin (Gibco, Santa Clara, CA)
at 4°C overnight. The epidermal sheets were separated from dermis by ®ne
forceps, and the epidermal cell suspension was prepared as reported
previously (Kao and Yu, 1991). The cells were pelleted by centrifugation
(500 3 g, 10 min) and resuspended in serum-free medium (Gibco). The
epidermal cell suspension was plated on to plastic 10 cm2 Petri dishes, and
incubated at 37°C in a humidi®ed atmosphere containing 5% CO2.
Twenty-four hours after primary seeding, the medium was changed, and
then changed regularly every 2 d. About 7±10 d after primary seeding, the
semicon¯uent melanocytes were incubated with 0.25% trypsin in 0.01%
ethylenediamine tetraacetic acid solution (Gibco) at 37°C for 3±5 min,
harvested with fetal bovine serum (Gibco), centrifuged (500 3 g, 10 min),
and the cell pellet was resuspended in serum-free medium and re-
incubated. The second-passage cells were used in the following
experiments.
V-IgG detection Second-passage cells were used for V-IgG detection.
The cells plated on coverslips were ®xed with 100% methanol at ±20°C for
3 min, incubated with puri®ed IgG from the patients with active vitiligo
[100 mg per ml in phosphate-buffered saline (PBS)] at room temperature for
60 min, then incubated with ¯uorescein isothiocyanate-conjugated rabbit
anti-human IgG (DAKO, Glostrup, Denmark, 1:50 diluted in PBS) at
room temperature for 60 min. Between each step, the cells were washed
with PBS three times. The samples were observed using an Olympus BX-
50 ¯uorescence microscope.
The individual puri®ed IgG was also measured for anti-melanocyte
activity by cellular enzyme-linked immunosorbent assay (cellular ELISA) as
reported previously (Yu et al, 1993). The melanocytes were subcultured
into chamber slides (Nalge Nunc International, Naperville, IL) and
incubated at 37°C in a humidi®ed atmosphere containing 5% CO2 for
24 h. Cells were ®xed in 100% ice-cold methanol for 3 min, washed three
times with PBS, and incubated with 100 mg per ml V-IgG or normal IgG
(N-IgG) at 37°C for 30 min. After washing with PBS three times, we
added 100 ml of rabbit anti-human IgG (1:50 diluted) for 30 min at room
temperature. Unbound rabbit anti-serum was washed three times with
PBS, and a pig anti-rabbit peroxidase anti-peroxidase kit (Dako PAP Kit,
K548) was used according to the manufacturer's instructions. Plates were
read at 490 nm in an ELISA reader, and the relative titer of anti-melanocyte
antibodies was expressed as optical density. Six samples containing the
highest titer of V-IgG and six N-IgG samples with average titers were then
individually used in the following experiments.
Measurement of cytokines in melanocyte supernatants by
ELISA The concentration of cytokines in the culture supernatants
derived from 2 3 105 melanocytes per ml after a 24 h incubation with
medium, V-IgG (100 mg per ml), N-IgG (100 mg per ml), or ultraviolet
(UV) B irradiation at 100 mJ per cm2 (served as a positive control) was
measured by commercially available ELISA kits including IL-8, IL-1a, IL-
1b, and interferon-g (IFN-g) (Quantikine, R&D Systems, Minneapolis,
MN). The results were presented as mean 6 SD. The detectable
concentration range was 31.2±2000 pg per ml for IL-8, 3.9±250 pg per ml
for IL-1a, 3.9±250 pg per ml for IL-1b and 15.6±1000 pg per ml for IFN-g.
The same experiment was repeated nine times. Unpaired Student's t test
was used to analyze the statistical differences between patients and controls.
A difference of p < 0.05 was considered as statistically signi®cant.
ICAM-1 and MHC class II detection by ¯uorescence-activated cell
sorter (FACS) analysis After an incubation of 72 h with either V-IgG
(100 mg per ml) or N-IgG (100 mg per ml) in 3.5 cm culture dishes,
melanocytes were detached with 0.25% trypsin in 1 mM ethylenediamine
tetraacetic acid·4Na, washed twice with PBS buffer, pH 7.2, then
incubated with ¯uorescein isothiocyanate-conjugated mouse anti-human
ICAM-1(Leinco Technologies, Ballwin, MO), HLA-DP, HLA-DQ, or
HLA-DR monoclonal antibody (Becton-Dickinson Immunocytometry
Systems, Mountain View, CA) (1:20 diluted in Isoton solution) for 30 min
in an ice-bath. Human recombinant tumor necrosis factor-a (TNF-a,
20 ng per ml) purchased from Quantikine, R&D Systems served as a
positive control. The expressions of ICAM-1 and MHC Class II were
detected by FACScan. Data were shown as mean ¯uorescence intensity
(MFI, denoted by mean channel number) of ICAM-1 or MHC class II-
positive cells. The same experiment was repeated nine times, and the
statistical signi®cance was analyzed by unpaired Student's t test. A
difference of p < 0.05 was considered as statistically signi®cant.
Reverse transcriptase-assisted polymerase chain reaction (reverse
transcriptase±PCR) detection of IL-8 mRNA IL-8 mRNA
expression in melanocytes after 6 h incubation with medium, V-IgG
(100 mg per ml), or N-IgG (100 mg per ml) was measured by reverse
transcriptase±PCR. One microgram of total RNA was reverse-transcribed
into cDNA in the presence of 100 pmol poly deoxythymidine (Promega,
Madison, WI), 1 mM deoxynucleoside triphosphate (Promega), avian
myeloblastosis virus reverse transcriptase (4 units) (Promega), and
1 3 reaction buffer (50 mM Tris (hydroxymethyl)±aminomethane±HCl,
50 mM KCl, 10 mM MgCl2,10 mM dithiothreitol, 0.5 mM spermidine) at
25°C for 10 min, 42°C for 40 min, 95°C for 10 min, and placed on ice. For
the PCR reaction, we used the following primers: IL-8 5¢-ACG-
AATTCCTAGGACAAGCCAGGAAG-3¢ (sense) and 5¢-GTGAAT-
TCAGTGTGGTCCACTCTCAATC-3¢ (anti-sense) (Paludan and
Thestrup-Pedersen, 1992), b-actin 5¢-GTGGGGCGCCCCAGGCA-
CCA-3¢ (sense) and 5¢-CTCCTTAATGTCACGCACGATTTC-3¢
(anti-sense). Five microliter aliquots of synthesized cDNA were added to
95 ml of the PCR mixture containing 10 ml of 10 3 PCR buffer (500 mM
KCl, 100 mM Tris (hydroxymethyl)±aminomethane±HCl, 1% Triton X-
100), 1 ml of sense and anti-sense primers (0.2 mM), 8 ml of 1.25 mM
deoxynucleotide triphosphates, and 0.5 ml of Taq DNA polymerase
(0.5 units per ml, Promega). The reaction mixture was overlaid with
80 ml of mineral oil. The mixture were then subjected to 35 cycles of 94°C
for 1 min, 60°C for 1.5 min, and 74°C for 2 min after an initial denaturation
step at 95°C for 5 min in a Hybaid OmniGene DNA Thermal Cycler
(Teddington, Middlesex, TW, UK). The PCR products were analyzed by
2% agarose gel electrophoresis and ethidium bromide staining. The DNA
fragments ampli®ed by these sets of primers were 253 bp for IL-8 and
548 bp for b-actin.
RESULTS
Anti-melanocyte activity of puri®ed IgG from active vitiligo
patients is signi®cantly higher than that from
controls Using the indirect immuno¯uorescence method, V-
IgG showed a positive reaction with methanol-®xed melanocytes.
Homogeneous ¯uorescence was found in the cytoplasm of the cells
by V-IgG (Fig 1A), in contrast very faint staining was noticed in
the cells by N-IgG (Fig 1B). By using methanol-®xed melanocytes
as substrates in cellular ELISA, the optical density at 490 nm for a
quantitative measure of anti-melanocyte activity of puri®ed IgG,
was signi®cantly higher in V-IgG (0.70 6 0.16) than N-IgG
(0.25 6 0.14) (p < 0.05) (Yu et al, 1997). The results indicated
that there was a higher anti-melanocyte antibody titer present in V-
IgG than that of N-IgG.
V-IgG-induced signi®cant increase in ICAM-1 and HLA-
DR on melanocytes In this study, we detected the expression
of ICAM-1 and MHC class II (DR, DP, and DQ) on cultured
melanocytes after incubation with either puri®ed IgG from the
patients with active vitiligo or normal IgG for nine experiments.
The mean ¯uorescence intensity of ICAM-1, HLA-DR, -DP, and
-DQ on V-IgG-, N-IgG-, TNF-a-stimulated and medium-
incubated melanocytes is shown in Table I. The results indicated
that the expression of ICAM-1 and HLA-DR, but not HLA-DP
and HLA-DQ, were signi®cantly higher on cultured melanocytes
incubated with V-IgG than incubated with N-IgG or medium
(p < 0.05, Table I, Fig 2).
V-IgG stimulated a signi®cant increase in IL-8 release by
melanocytes The release of IL-8 was signi®cantly higher in
cultured melanocytes incubated with V-IgG or UVB-irradiated
cells as compared with that of N-IgG or unstimulated cells
(p < 0.001, Table II) after nine experiments. In contrast, the release
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of IL-1a, IL-1b, and IFN-g were not in¯uenced by either V-IgG,
N-IgG, or UVB stimulation (Table II).
Reverse transcriptase±PCR detection of IL-8 mRNA in
melanocytes after incubation with V-IgG IL-8 mRNA
expression was detected by reverse transcriptase±PCR in
melanocytes after incubation with V-IgG or N-IgG for 6 h
(Fig 3). The cDNA was normalized to yield equivalent amounts
of b-actin to standardize the amount of total cellular mRNA in
each PCR reaction. The expression of IL-8 mRNA in IgG-
stimulated melanocytes was higher than that of the unstimulated
group. Furthermore, IL-8 mRNA expression in V-IgG-stimulated
melanocytes was signi®cantly higher than that of N-IgG-stimulated
melanocytes. These results were compatible with the ®ndings of
IL-8 production measured by ELISA.
DISCUSSION
Melanocytic cytotoxicity by immune mechanisms in vitiligo is a
complex process involving effector±target attachment via pairs of
adhesive molecules, activation of leukocyte receptors by target
antigens and other surface markers, and triggering of cytolysis
(Martz, 1987; Norris, 1990; Morelli and Norris, 1993).
Naughton et al (1983a) demonstrated that antibodies against
melanocyte surface antigens exist in the serum of vitiligo
patients. V-IgG were reported to induce melanocyte damage by
a complement-mediated mechanism and antibody-dependent
cellular cytotoxicity (Norris et al, 1988; Yu et al, 1993). V-
IgG directed against 40±45 kDa or 75 kDa common-tissue
antigens and a 65 kDa and 90 kDa pigment cell-speci®c antigen
have also been reported by many authors (Cui et al, 1992,
1995; Kao and Yu, 1992; Park et al, 1996). The biopsy
specimen of vitiligo lesions revealed an increase in the
expression of MHC class II antigens and ICAM-1 on
perilesional melanocytes (al Badri et al, 1993). Similar to type
I diabetes, coexpression of MHC class II antigens and ICAM-1
render the cells immunogenic to potentially auto-reactive T
lymphocytes (Campbell and Harrison, 1990).
In this study, three interesting ®ndings were observed: (i) V-IgG
stimulated HLA-DR expression on melanocytes; (ii) V-IgG
stimulated ICAM-1 expression on melanocytes; and (iii) V-IgG
induced an increase in IL-8 release from melanocytes. MHC class II
molecules can present exogenous antigens to CD4 helper cells and
are involved in certain cell±cell interaction and augment immune
responses (Dahl, 1996). Although no experiment was conducted in
this aspect, we speculate that the increased HLA-DR expression on
melanocytes may enhance the antigen-presenting activity on the
cells. In addition, increased expression of MHC class II antigens
per se may trigger lymphocyte reactions including cytotoxic T
lymphocytes (Campbell and Harrison, 1990), which may cause
melanocytolysis. ICAM-1, as a member of the integrin family, is
involved in cell±cell interactions of leukocytes and parenchymal
cells, and thus plays an important part in the induction of
immunologic and in¯ammatory reactions. The ligand for ICAM-
1 is leukocyte function associated antigen-1 which is expressed by
all leukocytes (Martz, 1987). Leukocyte function associated
antigen-1/ICAM±1 interactions have been shown to be important
for controlling cytotoxicity mediated by lymphokine-activated
killer cells (Kalish, 1989), cytotoxic lymphocytes (Shau et al, 1986),
and antibody-dependent cellular cytotoxicity effector cells
(Miedema et al, 1984). Once melanocytes express an excess of
adhesion molecules an increased susceptibility to immune cytotoxic
damage occurs. al Badri et al (1993) reported a signi®cant increase
in the expression of MHC class II and ICAM-1 on perilesional
melanocytes of vitiligo specimens. MHC class II and ICAM-1 play
important parts in normal antigen presentation and activation of
Table I. V-IgG induced a signi®cant increase in HLA-DR and ICAM-1 expression on melanocytesa
Fluorescence intensityb (% positive cells)
Group n = 9 HLA-DR HLA-DP HLA-DQ ICAM-1
V-IgG (100 mg per ml) 36.7 6 6.4c (5.34) 59.3 6 20.7 41.2 6 10.2 1268.7 6 157.6c (35.41)
N-IgG (100 mg per ml) 20.7 6 2.0 (0.85) 50.8 6 10.1 43.4 6 4.6 912.8 6 178.2 (20.57)
Medium 22.2 6 1.9 (0.64) 48.5 6 4.3 44.1 6 13.1 895.6 6 102.2 (15.32)
TNF-a (20 ng per ml) 32.6 6 5.2c (5.76) 57.3 6 7.3 45.8 6 6.8 1375.7 6 145.8c (32.14)
a The expression of MHC class II molecules (HLA-DR, -DP, and -DQ) and ICAM-1 on the cell surface of melanocytes was detected by ¯ow cytometry after
incubation with V-IgG, N-IgG, medium, and human recombinant TNF-a, as a positive control for 72 h. The same experiment was repeated nine times.
b The ¯uorescence intensity of the cells was denoted by mean ¯uorescence intensity (mean channel number) 6 SD.
c p< 0.05, calculated by unpaired Student's t test when comparing V-IgG or TNF-a group to N-IgG group.
Figure 1. Indirect immuno¯uorescence stain of methanol-®xed
cultured melanocytes by V-IgG or N-IgG. Homogeneous ¯uores-
cence staining pattern was found in the cytoplasm of the cells by V-IgG
(A); in contrast very faint staining was noticed in the cells by N-IgG (B).
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helper T lymphocytes, and their expression by melanocytes may
contribute to the abnormal immune response in vitiligo. In this
study, V-IgG induced a signi®cant increase in the expression of
HLA-DR and ICAM-1 of melanocytes (Table I). The result is
consistent with the report presented by al Badri et al (1993).
Elevated expression of ICAM-1 and MHC class II in association
with certain putative vitiligo antigens would allow for antigen-
speci®c immune-effector-cell attachment and cause melanocyte
cytotoxicity. Furthermore, in individuals with circulating anti-
bodies against vitiligo antigens, the serum may enhance the
antibody-dependent cellular cytotoxicity killing mechanism on
those melanocytes with increased melanocyte ICAM-1 expression
(Yohn et al, 1990). The reason for only a subpopulation of cells
responding with increased MHC class II and ICAM-1 expression
Figure 2. A representative FACS pro®le of
melanocyte HLA-DR and ICAM-1 expres-
sion. (A) HLA-DR; (B) ICAM-1. Nonspeci®c
auto¯uorescence (AF) background was de®ned to
the left of the vertical boundary line. Melanocytes
were incubated with medium (1), 20 ng per ml
TNF-a (2), 100 mg per ml N-IgG (3), or 100 mg
per ml V-IgG (4) for 72 h.
Table II. V-IgG stimulated a signi®cant increase in IL-8 release by melanocytesa
Concentration of cytokines (pg per ml, mean 6 SD)
Group n = 9 IL-8 IL-1a IL-1b IFN-g
V-IgG (100 mg per ml) 138.61 6 24.22b 0.03 6 0.07 0.11 6 0.16 0.27 6 0.10
N-IgG (100 mg per ml) 66.88 6 8.18 0.04 6 0.06 0.09 6 0.08 0.20 6 0.06
Medium 38.64 6 4.28 0.03 6 0.03 0.24 6 0.12 0.14 6 0.11
UVB (100mJ per cm2) 117.83 6 15.67b 0.03 6 0.02 0.21 6 0.09 0.08 6 0.05
aThe effect of V-IgG, N-IgG, and UVB irradiation on the different cytokine production by human cultured melanocytes (2 3 105 per ml) after 24 h incubation detected
by ELISA kit. The same experiment was repeated nine times
bp < 0.001, calculated by unpaired Student's t test when comparing V-IgG or UVB treated group with N-IgG group.
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on melanocytes in vitiligo specimens and in V-IgG stimulation
experiments is not known. Two possibilities could be responsible:
(i) the density of HLA-DR and ICAM-1 molecules on the surface
of either cultured melanocytes or biopsied tissues is not enough to
be detected by the methods used in all cells, or (ii) the melanocytes
in culture or in situ are not in the same stage of the cell cycle, and
therefore differentially susceptible for HLA-DR or ICAM-1
induction.
Some studies demonstrated that in¯ammatory reactions occur at
the margin of vitiligo, i.e., accumulation of lymphocytes and
activated T lymphocytes near surviving melanocytes (al Badri et al,
1993; Galadari et al, 1993; Moser et al, 1993). In this study, we
con®rmed IL-8 stimulatory effects of V-IgG on melanocytes, either
by ELISA or reverse transcriptase±PCR. In addition to melano-
cytes, V-IgG induced an increase in IL-8 release from cultured
keratinocytes (data not shown). It is conceivable that IL-8 is a
chemoattractant/activator for T lymphocytes (Taub et al, 1996) as
well as for polymorphonuclear leukocytes. The recruitment of T
lymphocytes to the site of vitiligo may be partly due to the
attraction of IL-8 release from both melanocytes and keratinocytes
stimulated by V-IgG; however, the cause of scanty polymorpho-
nuclear leukocyte in®ltration in the vitiligo lesion is not clear at the
present time. A previous study demonstrated a signi®cant increase
in spontaneous production of IL-6 and IL-8 by mononuclear cells
of patients with active vitiligo. V-IgG stimulates an increase in IL-6
production by peripheral mononuclear cells (Yu et al, 1997). It is
reported that IL-6 can induce the expression of cell surface ICAM-
1 on melanocytes (Kirnbauer et al, 1992). IL-6 secreted by T
lymphocytes and monocytes/macrophages in in¯ammatory reac-
tion at the margin of vitiliginous lesions may accentuate ICAM-1
expression on melanocytes in addition to V-IgG. Increased IL-8
production from melanocytes by V-IgG may speci®cally chemo-
attract T lymphocytes to the site of lesions to amplify the
in¯ammatory reaction and facilitate melanocytic cytotoxicity.
In conclusion, our results are consistent with the possibility that
V-IgG play an important role in melanocytic cytotoxicity immune-
mediated: (i) increased HLA-DR expression on melanocytes
enhances the antigen-presenting activity of the cells; (ii) ICAM-1
expression on melanocytes stimulates leukocyte/monocyte attach-
ment and immune-mediated cytotoxicity; and (iii) increased IL-8
production from melanocytes chemoattracts T lymphocytes to the
sites of lesions to increase melanocyte destruction.
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